Ketamine Versus Neostigmine in Ultrasound-Guided Transversus Abdominis Plane Block in Caesarean Section
Launched by ALEXANDRIA UNIVERSITY · Mar 5, 2025
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
A prospective, experimental double-blind control study will be conducted in Alexandria Main University Hospital after approval of the medical ethics committee of the Alexandria Faculty of Medicine and a written formal consent will be signed out from patients or their relatives. Patients will be double-blinded randomized into two equal groups (40 patients each) after receiving spinal anesthesia with 12.5 mg of 0.5% hyperbaric bupivacaine:
* Group 1: 40 patients received postoperative TAP block with 20 ml 0.25% plain bupivacaine (10ml 0.5% bupivacaine added to 10ml normal saline) and 0.5 mg/...
Gender
ALL
Eligibility criteria
- • Inclusion criteria
- • ASA physical status I or II patients.
- • Patients undergoing elective CS. Exclusion criteria
- • Patients undergoing emergent CS.
- • Patient refusal.
- • Allergy to local anaesthesia or any additive drug.
- • Coagulopathy.
- • Body mass index \> 35.
- • Peripheral neuropathy or chronic pain syndrome.
- • Localized infection.
About Alexandria University
Alexandria University, a leading academic institution in Egypt, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise to conduct rigorous studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, Alexandria University aims to contribute to the global body of medical knowledge and enhance the quality of patient care through evidence-based findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alexandria, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported